Vaccine Therapy With Tumor Specific p53 Peptides in Adult Patients With Low BurdenAdenocarcinoma of the Ovary.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Aldesleukin; Cancer vaccine-p53; Cancer vaccine-p53; Granulocyte-macrophage colony-stimulating factors; Interleukin-2; Sargramostim
- Indications Ovarian cancer
- Focus Pharmacogenomic; Therapeutic Use
- 06 Oct 2017 Biomarkers information updated
- 01 Jan 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov record.
- 01 Jan 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov record.